A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

Translated title of the contribution: A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

N. Snoeren, E.E. Voest, A.M. Bergman, O. Dalesio, H.M. Verheul, R.A.E.M. Tollenaar, J.R.M. van der Sijp, S.B. Schouten, I.H.M. Borel Rinkes, R. van Hillegersberg

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.
Original languageUndefined/Unknown
Pages (from-to)545
Number of pages1
JournalBMC Cancer
Volume10
DOIs
Publication statusPublished - 2010

Cite this